KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cvs Health (CVS) Equity Average (2016 - 2025)

Cvs Health (CVS) has disclosed Equity Average for 17 consecutive years, with $74.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 1.55% year-over-year to $74.2 billion, compared with a TTM value of $74.2 billion through Dec 2025, down 1.55%, and an annual FY2025 reading of $75.6 billion, down 0.82% over the prior year.
  • Equity Average was $74.2 billion for Q4 2025 at Cvs Health, down from $75.3 billion in the prior quarter.
  • Across five years, Equity Average topped out at $77.3 billion in Q2 2025 and bottomed at $70.4 billion in Q1 2021.
  • Average Equity Average over 5 years is $74.2 billion, with a median of $74.5 billion recorded in 2022.
  • The sharpest move saw Equity Average increased 8.66% in 2021, then decreased 4.15% in 2022.
  • Year by year, Equity Average stood at $74.7 billion in 2021, then decreased by 4.15% to $71.6 billion in 2022, then rose by 5.51% to $75.6 billion in 2023, then dropped by 0.21% to $75.4 billion in 2024, then fell by 1.55% to $74.2 billion in 2025.
  • Business Quant data shows Equity Average for CVS at $74.2 billion in Q4 2025, $75.3 billion in Q3 2025, and $77.3 billion in Q2 2025.